Laboratorios Farmaceúticos Rovi SA (ROVI)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Mar 14, 2025

$56.38

P/E Ratio

19.41

Market Cap

$2.85B

Mar 27, 2024May 3, 2024Jun 5, 2024Jul 5, 2024Aug 7, 2024Sep 9, 2024Oct 11, 2024Nov 15, 2024Dec 20, 2024Jan 29, 2025Mar 14, 2025$50.00$60.00$70.00$80.00$90.00$100.00
  • ROVI
Description
Add to research
View more

Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.

Metrics
Add to research
View more

Overview

  • HQMadrid, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerROVI
  • Price$56.377616-0.80%

Trading Information

  • Market cap$2.85B
  • Float36.11%
  • Average Daily Volume (1m)130,044
  • Average Daily Volume (3m)117,121
  • EPS$2.68

Company

  • Revenue$763.75M
  • Rev growth (1yr)-7.93%
  • Net income$136.88M
  • Gross margin58.88%
  • EBITDA margin27.07%
  • EBITDA$206.72M
  • EV$3.33B
  • EV/Revenue4.36
  • P/E19.41
  • P/S3.48
  • P/B4.65
  • Debt/Equity22.06
Documents
Add to research
View more